» Articles » PMID: 16562997

Molecular Field Extrema As Descriptors of Biological Activity: Definition and Validation

Overview
Date 2006 Mar 28
PMID 16562997
Citations 123
Authors
Affiliations
Soon will be listed here.
Abstract

The paper describes the generation of four types of three-dimensional molecular field descriptors or 'field points' as extrema of electrostatic, steric, and hydrophobic fields. These field points are used to define the properties necessary for a molecule to bind in a characteristic way into a specified active site. The hypothesis is that compounds showing a similar field point pattern are likely to bind at the same target site regardless of structure. The methodology to test this idea is illustrated using HIV NNRTI and thrombin ligands and validated across seven other targets. From the in silico comparisons of field point overlays, the experimentally observed binding poses of these ligands in their respective sites can be reproduced from pairwise comparisons.

Citing Articles

Design, Synthesis, and Mechanistic Anticancer Evaluation of New Pyrimidine-Tethered Compounds.

Reymova F, Sever B, Topalan E, Sevimli-Gur C, Can M, Tuyun A Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006082 PMC: 11859636. DOI: 10.3390/ph18020270.


Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction.

Hwang S, Jeon K, Lee H, Moon I, Jung S, Kim S Elife. 2024; 13.

PMID: 39641248 PMC: 11623927. DOI: 10.7554/eLife.97051.


Integrated computational approaches for identification of potent pyrazole-based glycogen synthase kinase-3β (GSK-3β) inhibitors: 3D-QSAR, virtual screening, docking, MM/GBSA, EC, MD simulation studies.

Niharika D, Salaria P, Reddy M Mol Divers. 2024; .

PMID: 39560899 DOI: 10.1007/s11030-024-11026-0.


Rational design and testing of new urease inhibitors to prevent urinary catheter blockage.

Heylen R, Cusick N, White T, Owen E, Patenall B, Alm M RSC Med Chem. 2024; .

PMID: 39281800 PMC: 11391341. DOI: 10.1039/d4md00378k.


Expanding the inhibitor space of the WWP1 and WWP2 HECT E3 ligases.

Dudey A, Rigby J, Hughes G, Stephenson G, Storr T, Chantry A J Enzyme Inhib Med Chem. 2024; 39(1):2394895.

PMID: 39223706 PMC: 11373361. DOI: 10.1080/14756366.2024.2394895.